Research programme: antifungal drug hyaluronan complex - Meditech ResearchAlternative Names: Antifungal drug hyaluronan complex research programme - Meditech Research
Latest Information Update: 07 May 2010
At a glance
- Originator Meditech Research
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 07 May 2010 Discontinued - Preclinical for Mycoses in Australia (unspecified route)
- 31 Dec 2001 Preclinical trials in Mycoses in Australia (unspecified route)